NCT00938665View on ClinicalTrials.gov

Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.

CompletedOBSERVATIONAL
Enrollment

204

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Memory DisordersAlzheimer DiseaseDementiaCognitive ImpairmentFrontotemporal Dementia
Interventions
DEVICE

COGNISION™ System

30 minute ERP test and 3 minute resting EEG data collected from cognitively healthy and AD to validate ERP and qEEG as useful cognitive biomarkers for AD.

Trial Locations (7)

19104

University of Pennsylvania, Philadelphia

27710

Duke University, Durham

33407

Premiere Research Institute, West Palm Beach

40202

Norton Healthcare, Louisville

40536

University of Kentucky, Lexington

02467

Boston Center for Memory, Brookline

05201

The Memory Clinic, Bennington

Sponsors

Lead Sponsor

Neuronetrix, Inc.
All Listed Sponsors
lead

Neuronetrix, Inc.

INDUSTRY

NCT00938665 - Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease. | Biotech Hunter | Biotech Hunter